未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
WNK1 promotes head and neck squamous cell carcinoma progression through activation of NF-κB signaling pathway WNK1通过激活NF-κB信号通路促进头颈鳞状细胞癌进展。 Chen, Ru-zhen; Li, Rui; Cheng, Bing-lin; Lu, Si-bei; Hu, Wen; Lin, Feng; Wen, Xin; Chen, Yue; Wang, Ying-lei; Zhang, Mo-ting; Hong, Xiao-hong; Tang, Xin-ran 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
First-in-human phase I study of EMB-02, a bispecific antibody targeting PD-1 and LAG-3 in patients with advanced solid tumors EMB-02的首次人体I期研究，EMB-02是一种靶向PD-1和LAG-3的双特异性抗体，用于治疗晚期实体瘤患者 Day, Daphne; Ganju, Vinod; Chung, Ki; Si, Lu; Mao, Lili; Aghmesheh, Morteza; Hoyer, Robert; Brewin, Kim; Zeng, Shuqi; Zhang, Mingfei; Lu, Qiaoyang; Jiang, Chengjun; Ren, Fang; Zhu, Yonghong; Guo, Jun 分享 收藏
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapy 一线全身性治疗对转移性上尿路尿路上皮癌患者生存的预后模型 Li, Siming; Wei, Jinchang; Xu, Huayan; Wu, Xiaowen; Li, Juan; Zhou, Li; Yan, Xieqiao; Tang, Bixia; Si, Lu; Cui, Chuanliang; Chi, Zhihong; Guo, Jun 分享 收藏
Dynamic Change of PD-L2 on Circulating Plasma Extracellular Vesicles as a Predictor of Treatment Response in Melanoma Patients Receiving Anti-PD-1 Therapy 循环血浆外泌体上PD-L2的动态变化作为接受抗PD-1治疗黑色素瘤患者治疗反应的预测指标 Sun, Linzi; Wei, Xiaoting; Zhao, Qian; Mao, Lili; Bai, Xue; Li, Caili; Gu, Junjie; Kong, Yan; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Lian, Bin; Wang, Xuan; Li, Siming; Yan, Xieqiao; Tang, Bixia; Zhou, Li; Li, Juan; Guo, Jun; Si, Lu; Dai, Jie 分享 收藏
分享 收藏
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study Disitamab vedotin联合toripalimab治疗局部晚期或转移性尿路上皮癌 (RC48-C014): Ib/II期剂量递增和剂量扩展研究 Zhou, L.; Yang, K. W.; Zhang, S.; Yan, X. Q.; Li, S. M.; Xu, H. Y.; Li, J.; Liu, Y. Q.; Tang, B. X.; Chi, Z. H.; Si, L.; Cui, C. L.; Guo, H. Q.; He, Z. S.; Guo, J.; Sheng, X. 分享 收藏
Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights 溶瘤病毒OH2延长PD-1预治疗黑色素瘤患者的生存期：Ia/Ib期试验结果及生物标志物见解 Wang, Xuan; Tian, Hui; Chi, Zhihong; Si, Lu; Hu, Han; Gu, Xiangyong; Li, Siming; Li, Caili; Lian, Bin; Zhou, Li; Mao, Lili; Tang, Bixia; Yan, Xieqiao; Wei, Xiaoting; Li, Juan; Liu, Binlei; Guo, Jun; Kong, Yan; Cui, Chuanliang 分享 收藏
Genomic characterization reveals distinct mutational landscape of acral melanoma in East Asian 基因组特征分析揭示了东亚肢端黑色素瘤独特的突变景观。 Zhang, Fenghao; Wu, Xiaowen; Jiao, Tao; Du, Haizhen; Guo, Qian; Cui, Chuanliang; Chi, Zhihong; Sheng, Xinan; Jiang, Dezhi; Zhang, Yuhong; Wu, Jiayan; Kong, Yan; Si, Lu 分享 收藏
RATIONALE-304 long-term outcomes: First-line tislelizumab (TIS) plus chemotherapy (chemo) vs chemo for locally advanced or metastatic non-squamous (NSQ) NSCLC RATIONALE-304长期结局：局部晚期或转移性非鳞状（NSQ）非小细胞肺癌（NSCLC）中，一线替雷利珠单抗（TIS）联合化疗（chemo）与化疗（chemo）的对比。 Ma, Z.; Yu, Y.; Yu, X.; Li, X.; Cui, J.; Wang, D.; Wang, X.; Wu, J.; Huang, D.; Li, G.; Zhao, N.; Liang, L.; Song, M.; Lu, S. 分享 收藏
Pharmacological targeting of casein kinase 1δ suppresses oncogenic NRAS-driven melanoma Wen, Yalei; Wang, Hui; Yang, Xiao; Zhu, Yingjie; Li, Mei; Ma, Xiuqing; Huang, Lei; Wan, Rui; Zhang, Caishi; Li, Shengrong; Jia, Hongling; Guo, Qin; Lu, Xiaoyun; Li, Zhengqiu; Shen, Xiangchun; Zhang, Qiushi; Si, Lu; Yin, Chengqian; Liu, Tongzheng 分享 收藏
MET amplification correlates with poor prognosis and immunotherapy response as a subtype of melanoma: a multicenter retrospective study Cai, Xiaojun; Lin, Jing; Li, Caili; Xu, Ting; Chen, Chuanben; Lan, Bin; Wang, Xuefeng; Bai, Shengjie; Huang, Yufang; Zhang, Huishan; Si, Lu; Chen, Yu 分享 收藏
Bioinformatics analysis of immune infiltration in human diabetic retinopathy and identification of immune-related hub genes and their ceRNA networks Li, Jingru; Li, Chaozhong; Wu, Xinyu; Yu, Shuai; Sun, Guihu; Ding, Peng; Lu, Si; Zhang, Lijiao; Yang, Ping; Peng, Yunzhu; Fu, Jingyun; Wang, Luqiao 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
